05.4 ovpmc/ariclesPMC)PMID8(https:/ww.ncbi.nim.nih.govpubmed/19 (hip://1 prot.2009.3). Qingzhao:Swiatkowski, Mike:Mathias,Melissa:Garman.Lor:Helms.Christina (2009-01-16)"Functional anergy ina P3SSSN1540-g38 ss5a0.9538.pC2626668htps d1910387 doi.org/ub Le 306 11 Turk.Ellen:Kang. 89).doi:10.1038/nprot..2013.117htps/doi.org/10.1038%2 Fnprot..2013.7 12 asak lonescu R (2008)."Hetergeneity of nsitive pubmed/19075686.dot10.2174138920108786786402 do.0r/10.21749%2F1389201 0.105:345-52.pMlD20414207 142Yhmd2o41427ot101038am277tps1oiomgn020207 D Ni variants in IgG1:Isolation,characterization,in vitro binding erties and pharmacokinetics in rats"(ht sbio cience.com/journals/mabs/abstract.php? 818176 cn6gNpbmd20e18176o416261333ps0oog91014161%m 2.6.13333) J.CanoT(A ink of iV0021-967311)00722-9). Chromato A.1218(315 86.PMID 21700290 (https://w w.ncbi.nl m/)doi-0.1016/j-chroma20105061(h:/)chroma 16.Rathore AS,Winkle H(January 2009)."Quality by design for biophar euticals".Nat.Biotechnol.27 (126 34PD19131992tps ww.ncbi.nlm.nih.gov/pubmed/19131992).doi:10.1038/nbt0109-26 17 caise de transfus ne.9(1):1 22 PMID 1889896 (hup 18."Dr.George Pieczenik"(http://www2.mrc-Imb.cam.ac.uk/component/content/article/40-archive/200-arch 1ve-servic alumni). Biology(LMB).17 2009. tion of antibodie S106-S12 PMID 10831134 (hutps:/www ncbi.nlm.nih.gov/pubmed/10831134).doi:10.1053/plac.1999.0511(https://doi.org/10.1053%2Fplac.199 20 Chadd HE.Chamow SM(A Biotechnol.12(2) 1128723 10.1016%2S095 9%8800%06d9287236).do:10.1016s0958-1669(0)y00198 21.Lonbe g N.Hus rD(9)."Human antibodies from transge ic mice".Int.Rev.Immunol.13(1):65- 710302030i0g0t87494109do1031008a301s50906i738 .org/1